Category: On CallSyndicate content

Survey: Male docs earned 24% more in 2013 | On Call

April 21, 2014 by Arezu Sarvestani

A new survey of U.S. physicians finds substantial differences in the rate of pay for men and women in the profession, but the gap appears to be closing. On Call

MASSDEVICE ON CALL — A new survey of more than 24,000 U.S. physicians found major disparities in income between male and female doctors, although it's a gap that appears to be narrowing.

Male doctors in 2013 earned about 23.6% more than their female counterparts, taking home an average of $267,000, compared with female doctors' average take-home of $225,000. That gap was larger in 2010, with male doctors' salaries about 28% higher than women's.

Report: Docs excuse iffy procedures when money is on the line | On Call

April 16, 2014 by Arezu Sarvestani

Medical societies asked to name potentially needless treatments tend to leave out procedures that put money in their pockets, according to a Kaiser Health News/Chicago Tribune report. On Call

MASSDEVICE ON CALL — A survey of U.S. medical groups found that few are willing to criticize uncertain treatments that put money in their members' pockets.

When asked about potentially needless procedures, most doc groups cited treatments that were rarely used in practice or named procedures belonging to specialties other than their own. Most stood behind treatments that are considered uncertain yet lucrative, according to a joint report by Kaiser Health News and the Chicago Tribune.

Is there an Obamacare silver lining for medtech? | On Call

April 15, 2014 by Arezu Sarvestani

Wall Street analyst writer Sean Williams speculates that the Affordable Care Act, complete with the medical device tax, may actually help spur innovation rather than hamper it. On Call

MASSDEVICE ON CALL — Wall Street analyst and Motley Fool writer Sean Williams sees an Obamacare upside for the medical device industry, despite the doom and gloom forecast usually spurred by talk of the medical device tax.

Yet another warning letter for Hospira | On Call

April 14, 2014 by Arezu Sarvestani

FDA regulators issue a formal warning asking Hospira to provide more information on steps taken to address quality control issues highlighted in previous notices. On Call

MASSDEVICE ON CALL — Drug pump maker Hospira (NYSE:HSP) was the subject of another FDA warning letter posted this month, in which FDA officials asked for more information about steps taken to address quality control violations.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Consumers group aims to take down J&J and CEO Gorsky | On Call

April 11, 2014 by Arezu Sarvestani

The Corporate Action Network is taking aim at Johnson & Johnson and CEO Alex Gorsky, asking for tips about wrongdoing at the company. On Call

MASSDEVICE ON CALL — The Corporate Action Network is looking for tips to help take down healthcare giant Johnson & Johnson (NYSE:JNJ) and its CEO, Alex Gorsky.

Hypertension: Docs turn on renal denervation | On Call

April 10, 2014 by Arezu Sarvestani

U.S. and E.U. cardiologists call for a hard check on global sales of renal denervation technology in the wake of Medtronic's disappointing SYMPLICITY HTN-3 study. On Call

MASSDEVICE ON CALL — A group of cardiologists is taking a hard stance against renal denervation, calling for medical device manufacturers to stop selling the technology as a treatment for hypertension.

Over-stenting doc costs bosses $37M in patient complaints | On Call

April 9, 2014 by Arezu Sarvestani

Maryland-based St. Joseph Medical Center's former owner agrees to pay up to $37 million to settle allegations that a former cardiologist put as more than 270 patients through unnecessary stenting procedures. On Call

MASSDEVICE ON CALL — A years-old over-stenting dispute is coming to a head as the former owner of St. Joseph Medical Center in Maryland agreed to pay up to $37 million to resolve patient lawsuits.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp